Skip to content

Clinical trials

Hemophilia B trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemophilia B Country / region: Canada Clear all

41 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20072
20092
20101
20114
20121
20132
20143
20151
20161
20171
20185
20194
20202
20212
20223
20231
20244

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22
Recruiting8
Terminated4
Unknown status4
Active, not recruiting2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer9
Novo Nordisk A/S7
CSL Behring3
McMaster University3
ApcinteX Ltd2
Bioverativ Therapeutics Inc.2
Regeneron Pharmaceuticals2
The Hospital for Sick Children2
University Health Network, Toronto2
Equilibra Bioscience LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemophilia B41
Hemophilia A24
Hematologic Diseases3
Hemorrhage3
Blood Coagulation Disorders2
Blood Coagulation Disorders, Inherited2
Coagulation Protein Disorders1
Factor VII Deficiency1
Genetic Diseases, Inborn1
Genetic Diseases, X-Linked1

Trials

Showing 1 to 25 of 41. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.